Retinal cases & brief reports · 2026
NEURORETINITIS ASSOCIATED WITH COVID-19 INFECTION AND VARICELLA-ZOSTER VIRUS REACTIVATION.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gavrić Ana Uršula, Mylemans Evelien Margareta, Vidovič Valentinčič Nataša
Аннотация
PURPOSE: To report a case of neuroretinitis as the presenting manifestation of COVID-19 infection alongside varicella-zoster virus reactivation, in the absence of other systemic symptoms.
METHODS: A case report.
RESULTS: A previously healthy 15-year-old boy presented with a 1-week history of acute unilateral visual loss and clinical findings consistent with neuroretinitis. Diagnostic work-up revealed a positive polymerase chain reaction test of nasopharyngeal swab for COVID-19 and serology showed the presence of immunoglobulin M and immunoglobulin G antibodies for varicella-zoster virus. After a comprehensive treatment regimen involving IV acyclovir, high-dose IV steroids, and oral doxycycline, rapid and remarkable improvements were observed. The macular star and optic disk swelling regressed, and visual acuity improved from 20/200 to 20/20.
CONCLUSION: This case offers valuable insights into the neuroretinitis associated with COVID-19 infection and varicella-zoster virus reactivation.
METHODS: A case report.
RESULTS: A previously healthy 15-year-old boy presented with a 1-week history of acute unilateral visual loss and clinical findings consistent with neuroretinitis. Diagnostic work-up revealed a positive polymerase chain reaction test of nasopharyngeal swab for COVID-19 and serology showed the presence of immunoglobulin M and immunoglobulin G antibodies for varicella-zoster virus. After a comprehensive treatment regimen involving IV acyclovir, high-dose IV steroids, and oral doxycycline, rapid and remarkable improvements were observed. The macular star and optic disk swelling regressed, and visual acuity improved from 20/200 to 20/20.
CONCLUSION: This case offers valuable insights into the neuroretinitis associated with COVID-19 infection and varicella-zoster virus reactivation.